Hrt Financial LP Artivion, Inc. Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$24.33 - $28.46 $858,703 - $1 Million	35,294 New	35,294 $939,000
Q3 2023 Nov 13, 2023	BUY	$14.82 - $17.52 $380,844 - $450,228	25,698 New	25,698 $389,000
Q1 2023 May 12, 2023	BUY	$11.74 - $14.12 $394,557 - $474,544	33,608 New	33,608 $440,000
Q4 2021 Feb 14, 2022	SELL	$17.19 - $22.84 $554,635 - $736,932	-32,265 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.29 - $28.7 $421,236 - $542,372	18,898 Added 141.38%	32,265 $719,000
Q2 2021 Aug 16, 2021	SELL	$22.32 - $32.07 $172,823 - $248,318	-7,743 Reduced 36.68%	13,367 $379,000
Q1 2021 May 17, 2021	BUY	$22.07 - $26.31 $465,897 - $555,404	21,110 New	21,110 $476,000
Q4 2020 Feb 16, 2021	SELL	$16.76 - $23.74 $397,144 - $562,543	-23,696 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$16.35 - $21.4 $387,429 - $507,094	23,696 New	23,696 $437,000

176

37.1M

20.5K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.21B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.